Cataract surgeons know that you can\u2019t have it all when it comes to replacing the eye\u2019s natural crystalline lens. But with today\u2019s advanced optics, patients are getting closer than ever to achieving quality vision at all distances. Truly non-diffractive optics like on Rayner\u2019s RayOne EMV are leading the charge, and top names from the cataract and refractive world broke it all down at ESCRS 2023.<\/em><\/p>\n Intraocular lenses (IOLs) have come a long way since the introduction of the first multifocal IOL at the European Intra-Ocular Implant Council (EIIC) meeting in Copenhagen, Denmark, in 1988. Thirty-five years later, at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS 2023 in Vienna, Austria), a new revolution in optics is underway.<\/p>\n In a Rayner-sponsored symposium at the ESCRS congress, some of the most sought-after minds in cataract and refractive surgery examined the prospects of advanced non-diffractive optics, and lenses using positive spherical aberration (SA) like Rayner\u2019s RayOne EMV IOL. From the optical bench to in vivo<\/em> clinical studies of the lens, Dr Damien Gatinel, Prof. Oliver Findl and Mr Allon Barsam showed what RayOne EMV, and its novel controlled positive SA design, offers patients and surgeons.<\/p>\n Prof. Graham Barrett, who collaborated with Rayner on the RayOne EMV, introduced the theme of balance with his opening reflection on modern IOL designs. The trade-off with the extreme range of vision with multifocal lenses is a sacrifice in quality.<\/p>\n <\/p>\n <\/p>\n \u201cHow well will the patient tolerate this?\u201d he asked the audience. His answer \u2013 and by extension, RayOne EMV\u2019s \u2013 is clear in the decision to shun diffractive optics in the lens design to minimise dysphotopsia and photic phenomena.<\/p>\n For Prof. Barrett, this is a large part of the formula for success with IOL optics. \u201cWhen you look at the options and the balance between quality and range of vision, an extended-depth-of-focus (EDF) or monofocal plus lens such as the RayOne EMV, which utilises positive spherical aberration, gives you that best balance,\u201d he stated.<\/p>\n <\/p>\n It was then into the lab with Dr Damien Gatinel of the Rothschild Foundation in Paris. In his talk entitled, Non-diffractive Advanced Optics: Reality or myth?<\/em>, Dr Gatinel took Prof. Barrett\u2019s musings to the optical bench, where fact-checking manufacturer claims about optical designs yielded intriguing insights.<\/p>\n Dr Gatinel began his presentation by pointing out that not all lenses claiming to be non-diffractive are actually non-diffractive, and he showed this with a side-by-side comparison of a leading EDOF lens (Alcon AcrySof IQ Vivity) and Rayner\u2019s RayOne EMV.<\/p>\n \u201cI wouldn\u2019t be able to say that the [RayOne EMV] is a refractive monofocal or a refractive multifocal because it\u2019s smooth. But with [the other lens], I see concentric zones which evoke a diffractive structure or element or a combined refractive structure […] there\u2019s diffraction optically speaking,\u201d Dr Gatinel explained.<\/p>\n More testing revealed that RayOne EMV really does have a truly non-diffractive optic. Using a NIMO TEMPO (Lambda-X Ophthalmics; Belgium) confirmed that RayOne EMV is exactly what Rayner claims it is.<\/p>\n \u201cWhen we compared [our findings] to what the manufacturer provided as a description, we were pleased to see that it’s similar to what Rayner disclosed,\u201d Dr Gatinel said. \u201cSo, there is transparency \u2013 not only with the lens material but in the communications on the optical element provided to doctors.\u201d<\/p>\n \u201cRayner is a company that so far accurately explains their advanced technologies. The RayOne EMV is a fully non-diffractive IOL, and the depth-of-focus has been shown to be at least 1.5 dioptres throughout a wide range of pupil sizes,\u201d he concluded.<\/p>\n <\/p>\n ESCRS President Prof. Oliver Findl was up next to explain what this all means for patients in the real world, in his talk Results from a Comparative Prospective Study with RayOne EMV<\/em>.<\/p>\n In the randomised controlled single-centre study, 48 patients were implanted with Rayner\u2019s RayOne EMV and the Alcon AcrySof IQ Vivity. The dominant eye was targeted for emmetropia and the non-dominant for -0.5 D, or mini-monovision.1<\/sup><\/p>\n The Alcon AcrySof IQ Vivity being compared to RayOne EMV in Prof. Findl\u2019s study was labelled as non-diffractive, but was nonetheless found in Dr Gatinel\u2019s laboratory investigation to contain diffractive elements. And while this would imply that there would be significant differences in range of vision and visual acuity between the two lenses, Prof. Findl’s study showed this was not the case.<\/p>\n \u201cYou can see for the Rayner and the Alcon [lenses], there is actually no difference for distance,\u201d Prof. Findl noted, pointing to the 90% of patients with uncorrected distance visual acuity (UDVA) of \u22640.0 logMAR. And when comparing the two lenses\u2019 defocus curves, Prof. Findl ended up giving a slight edge to RayOne EMV for distance and very similar results for intermediate distance. \u201c[The Alcon lens] is a little worse at distance,\u201d he said. The Vivity IOL did, however, have slightly better near-acuity results than the EMV IOL.<\/p>\n Despite the similar performances of these lenses \u2013 one with a smooth optic and another with diffractive elements \u2013 at distance, the biggest differences came with quality of vision. For contrast sensitivity, it was all RayOne EMV. \u201cThe Vivity is actually lower in many of these spatial frequencies,\u201d Prof. Findl noted. And for halos, the results were also clear. \u201cThe halo size for the Vivity is larger, and that\u2019s also statistically significant.\u201d<\/p>\n <\/p>\n <\/p>\n In wrapping up his presentation, Prof. Findl gave his final verdict on RayOne EMV. \u201cFrom my perspective, the RayOne EMV is especially suited for monovision,\u201d he began. \u201cBut you can also use it as your standard monofocal IOL with very good contrast sensitivity. The photic phenomena seem to be comparable to standard monofocal IOLs,\u201d he added.<\/p>\n He was also impressed with the RayOne EMV\u2019s range of vision. \u201cEssentially, you will have uncompromised binocular distance vision. You will have some benefit for intermediate vision \u2013 and sometimes even some useful near vision,\u201d concluded Prof. Findl.<\/p>\n <\/p>\n Mr Allon Barsam, the London-based ophthalmologist who implanted the world\u2019s first RayOne EMV in 2020, picked up the torch from Prof. Findl as he also described clinical data comparing RayOne EMV to the Alcon AcrySof IQ Vivity.<\/p>\n Mr Barsam sought to show how Rayner\u2019s claims and clinical study results, like Prof. Findl\u2019s, would hold up in a much larger cohort \u2013 820 eyes in 517 patients. His findings went beyond Prof. Findl\u2019s takeaways about the differences between RayOne EMV and the Alcon AcrySof IQ Vivity.<\/p>\n \u201cIn this big, real-world retrospective study, there was statistically significant better uncorrected distance visual acuity and corrected distance visual acuity [with RayOne EMV],\u201d he said. \u201cThere was no significant difference in uncorrected intermediate visual acuity.\u201d<\/p>\n Mr Barsam\u2019s study also reached deeper into the patient side of things, and a digital post-op questionnaire using RayPRO (Rayner) yielded high patient satisfaction scores, to the tune of 84% of respondents for RayOne EMV versus 78% for the Alcon AcrySof IQ Vivity. \u201cWe presume this difference in satisfaction to be due to the tolerability of mini-monovision or the improved distance vision you get with RayOne EMV,\u201d he inferred.<\/p>\n <\/p>\n <\/p>\n When thinking about further research needed, Mr Barsam noted the relevance of a cost-benefit analysis between the RayOne EMV and AcrySof IQ Vivity, with Mr Barsam describing the cost difference as \u201cenormous\u201d given the modest variance in performance between the two lenses.<\/p>\n In the end, Mr Barsam\u2019s voice joined the chorus of praise for RayOne EMV and non-diffractive optics. \u201cWith the RayOne EMV, we clearly have a technology that maximises the quality of vision[…] and I think that\u2019s reflected in patient satisfaction,\u201d he summarised.<\/p>\n \u201cWhat patients really want is good quality of vision \u2013 and spectacle independence, or a degree thereof, they see as a bonus, especially if you can get them a bit more [near vision],\u201d added Mr Barsam. And for Profs. Barrett, Findl, Dr Gatinel and Mr Barsam, this is the promise of the RayOne EMV and its fully non-diffractive optic that utilises controlled positive SA \u2013 and the research shows the power of what this makes possible for the patient and the surgeon.<\/p>\n![\"\"](\"https:\/\/rayner.com\/peer2peer-es\/wp-content\/uploads\/sites\/18\/2023\/10\/Picture-.png\")
<\/p>\nClaims vs. reality on the optical bench<\/h2>\n
Head-to-head<\/h2>\n
![\"\"](\"https:\/\/rayner.com\/peer2peer-es\/wp-content\/uploads\/sites\/18\/2023\/10\/Picture-2.png\")
<\/p>\nMore patients, better results?<\/h2>\n
![\"\"](\"https:\/\/rayner.com\/peer2peer-es\/wp-content\/uploads\/sites\/18\/2023\/10\/Picture-3.png\")
<\/p>\nWatch the full symposium<\/a>\u00a0<\/strong><\/span><\/h3>\n
Learn more about RayOne EMV at www.rayner.com\/EMV<\/a><\/strong><\/span><\/h3>\n
<\/h3>\n
Reference<\/h3>\n